Compassionate use: Putting drug regulations to the test
When should pharmaceutical companies grant compassionate use of experimental treatments? How readily available should the drugs be? A PBS news segment considers these issues.
When should pharmaceutical companies give gravely ill patients access to experimental treatments? The above news segment offers an good summary of the issues involved in this vexed ethical dilemma.
Compassionate Use Putting drug regulations to the test
Xavier Symons
https://www.bioedge.org/images/2008images/TH_savejosh.jpg
Creative commons
clinical trials
compassionate use
- Can machines be moral? - March 7, 2021
- Can we synthesise Christianity moral theology with secular bioethics? - November 28, 2020
- Euthanasia polling data may fail to capture people’s considered views - August 15, 2020
More Stories
BioEdge has closed its doors
After 23 years, BioEdge ceased published in May 2024. Not that there isn't lots to report on and talk about,...
How liberal are American bioethicists?
There is growing acknowledgement of the fact that the backgrounds, ideas, and politics of American academics are out of step...
Doctors can be socialized to cooperate in morally despicable evil, says bioethicist
Bioethicist Carl Elliott seems to relish stirring up fellow bioethicists and the medical profession. In his latest book, The Occasional Human...
3 sperm donors from same family in Quebec have sired 600 children
Three men in Quebec from the same family have fathered more than 600 children by offering free sperm on the...
American IVF clinics are happily offering sex selection
The United States is one of the few countries where IVF sex selection is legal – and it is a...
Owner of castration website in UK found guilty of grievous bodily harm
“Enhancement” normally connotes adding powers beyond normal human functioning. However, there are dark kinds of enhancement which remove them. A...